top of page
.png)
ABOUT i-RNA
From discovery to therapeutic development
i-RNA was founded from research at Western University led by Dr. Subrata Chakrabarti, building on discoveries in non-coding RNA biology and diabetic complications. Today, we are advancing RNA therapeutics for retinal disease, with R&D operations in Canada and Hong Kong.
Research in the Chakrabarti Lab at Western University.
OUR FOCUS
Advancing RNA therapeutics for retinal disease
SCIENCE
Novel RNA targets in retinal disease
DEVELOPMENT
Advancing RNA discoveries into therapeutic candidates
DELIVERY
Advancing less invasive approaches to ocular treatment
OUR TEAM
Expertise across science, development and commercialization
Our team brings together expertise in retinal disease biology, RNA therapeutics, drug development, commercialization and operations.
Dr. Subrata Chakrabarti
Co-founder & CSO
Dr. Ting Ling
Co-founder & CEO
Ruby Zhao
Co-founder & COO
Paul Girolametto, CPA, CA
CFO (fractional)
Dr. Chantal Martin
TechOps & CMC Lead (fractional)
Dr. Eric Wang
Senior R&D Scientist
Julia Steriopoulos, MSc
R&D Scientist
I-RNA ASIA
Our R&D presence in Hong Kong
i-RNA Asia operates from Hong Kong Science Park as part of HKSTP's Incu-Bio programme.
Dr. Aimin Xu
Co-founder & Director
i-RNA Asia
Rowena Au
Research Associate & Lab Operations Coordinator
Wenyu Huang
Research Associate & Lab Operations Coordinator
bottom of page